Two Silicon Valley investors venture out on their own
moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click here to view […]
NSTG
NanoString’s CEO Discusses Q4 2013 Results – Earnings Call Transcript
[at Seeking Alpha] – Bradley Gray Thank you, Lynn. Good afternoon and thank you for joining us on our Q4 call. 2013 was a transformational year for NanoString. Our strategy to become an indispensable part of cancer research … moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring […]
NANOSTRING TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click here to view […]
NanoString Technologies Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook
[GlobeNewswire] – – Strong Q4 2013 Revenue Growth of 56% Year over Year – – Record Q4 2013 Instrument Revenue of $5.3 Million, Up 109% Year over Year – – Full Year Total Revenue of $31.4 Million, Up 37% Year over Year -… moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee […]
NanoString Technologies to Participate in the Cowen 34th Annual Health Care Conference
[at noodls] – SEATTLE, Feb. 19, 2014 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Cowen 34th Annual Health Care Conference in … moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click here to view […]
7:31 am NanoString Technologies announces study confirms ability of the Prosigna Assay to assess risk of late distant recurrence in postmenopausal women with estrogen receptor-positive breast cancer; authors conclude that the PAM50-based Pr
moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click here to view […]
Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant Recurrence in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer
[Business Wire] – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in Clinical Cancer Research showed that the PAM50 assay, on whic moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click […]
NanoString Technologies Launches Commercial Reagents to Enable Laboratories to Rapidly Develop Tests From Translational Research Discoveries
[Business Wire] – NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced the global commercial launch of the nCounter Elementsâ„¢ General Purpose Reagents , a solutio moreView todays social media effects on NSTGView the latest stocks trending across Twitter. Click to view dashboardSee who NanoString is hiring next, click here […]
